Cannabis Avicanna sponsors University of Calgary’s ‘sensitive dosing window’ medical THC study It aims to identify an optimal dosing regimen for patients that minimizes anxiety Rowan DunneMarch 18, 2026
Medical and Pharmaceutical Immutep completely tanks after discontinuing lung cancer drug trial Shares dropped by 88% on Friday the 13th, leaving investors shook Rowan DunneMarch 16, 2026
Medical and Pharmaceutical FDA clears Median Technologies lung-nodule risk assessment software The Median system reported 93.3 per cent sensitivity and 92.4 per cent specificity when identifying malignant lung nodules Joseph MortonMarch 16, 2026
Medical and Pharmaceutical Medtech company Vitestro pulls US$70M together for autonomous blood draw tech 'Aletta' uses AI and 3D ultrasound guidance for proper placement of a robotic needle Rowan DunneMarch 16, 2026
Medical and Pharmaceutical Medtronic spin-out MiniMed lists on Nasdaq, attains EU approval for diabetes tech MiniMed makes insulin delivery and glucose monitoring devices Rowan DunneMarch 13, 2026
Medical and Pharmaceutical 60 Degrees Pharma flies after curing tick disease in small-scale study The company is planning an NDA submission for its flagship drug as a Babesiosis treatment Rowan DunneMarch 12, 2026
Medical and Pharmaceutical bioAffinity launches 2,000-patient study for noninvasive lung cancer test The test analyzes sputum samples using flow cytometry to identify cancer-related cellular changes Joseph MortonMarch 11, 2026
Medical and Pharmaceutical Acurx Pharma shares rise by 29% on new trial for breakthrough antibiotic ‘ibezapolstat’ Investors are optimistic about the therapeutic's potential as a superior alternative for CDI treatment Rowan DunneMarch 11, 2026
Medical and Pharmaceutical Monash University’s medical engineering institute progresses silicosis breath test Its MedTech Commercialisation Advancement Program has been expediting the tool's development Rowan DunneMarch 9, 2026
Medical and Pharmaceutical Tango Therapeutics rallies after oncology drug collaboration with Erasca Researchers think combining both drugs could create stronger and longer-lasting tumor responses Joseph MortonMarch 5, 2026